An additional treatment option with TAGRISSO® (osimertinib) (Sponsored) episode artwork

EPISODE · Jan 10, 2025 · 14 MIN

An additional treatment option with TAGRISSO® (osimertinib) (Sponsored)

from The Top Line · host Fierce Life Sciences

Arun Krishna, Vice President and franchise head for an AstraZeneca US OBU, shares details of a treatment option with TAGRISSO® (osimertinib). AstraZeneca is focused on the development of new treatments, prioritizing researching options in eligible patients. Listen to the full podcast episode to learn more. Please see Important Safety Information for TAGRISSO. Please see complete Prescribing Information, including Patient Information for TAGRISSO.See omnystudio.com/listener for privacy information.

Arun Krishna, VP and franchise head for an AstraZeneca US OBU, discusses a treatment option for patients.

NOW PLAYING

An additional treatment option with TAGRISSO® (osimertinib) (Sponsored)

0:00 14:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Top Line?

This episode is 14 minutes long.

When was this The Top Line episode published?

This episode was published on January 10, 2025.

What is this episode about?

Arun Krishna, Vice President and franchise head for an AstraZeneca US OBU, shares details of a treatment option with TAGRISSO® (osimertinib). AstraZeneca is focused on the development of new treatments, prioritizing researching options in eligible...

Can I download this The Top Line episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!